Physician profile
Manish A Parikh
NPI 1891882965
$235,847.63
in general payments reported to CMS, 2019-2025
55 companies · $28K in 2025
The $28K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93K · 2020: $19K · 2021: $19K · 2022: $27K · 2023: $14K · 2024: $36K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $29K · Food and Beverage: $23K · Travel and Lodging: $10K · Honoraria: $5,500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,188 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,500 · Education: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,955.00 |
| Food and Beverage | $23,203.10 |
| Travel and Lodging | $10,307.41 |
| Honoraria | $5,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,187.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,500.00 |
| Education | $286.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $94,018.13 | 2019-2025 | Avvigo Guidance System, General - Vascular Access, Resonate El Icd Vr |
| Medtronic, INC. | $35,638.00 | 2021-2025 | Symplicity G3, Onyx Frontier, Hawkone |
| Medtronic Vascular, INC. | $30,409.34 | 2019-2020 | |
| Abbott Laboratories | $9,888.23 | 2019-2024 | Dragonfly Opstar, Optis |
| Siemens Medical Solutions USA, INC. | $9,562.88 | 2019-2024 | |
| Cardiovascular Systems INC. | $9,073.21 | 2019-2021 | |
| Corindus INC. | $6,821.19 | 2019 | |
| Shockwave Medical, INC | $5,963.05 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5,000.00 | 2021-2025 | Lifevest |
| Recor Medical INC | $4,741.82 | 2025 | Paradise Ultrasound Renal Denervation System |
| Biotronik INC. | $4,135.47 | 2019-2024 | Acticor 7 Vr-T Dx, Nhancer Rx, Trapit |
| Ge Healthcare | $3,381.62 | 2024 | |
| Asahi Intecc USA, INC. | $1,641.35 | 2024-2025 | Peripheral Vascular, Asahi Coronary Wires |
| Endologix LLC | $1,600.37 | 2025 | Endocross Device, Torus Stent Graft System |
| Philips North America LLC | $1,573.81 | 2019-2025 | Coronary Other, (6574) Coronary Other, (P88) Igt Devices Fm |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,382.11 | 2019-2025 | Impella |
| Cordis US Corp. | $1,356.37 | 2022-2025 | Mynx Control, Selution Slr Ptca, Mynx Control Venous |
| Inari Medical, INC. | $986.39 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $879.37 | 2019-2024 | Repatha |
| Kestra Medical Technology Services, INC. | $637.64 | 2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $615.98 | 2019-2025 | Farxiga |
| Terumo Medical Corporation | $602.30 | 2020-2025 | Glidewire, Glidesheath Slender, Angio-Seal |
| Novartis Pharmaceuticals Corporation | $601.94 | 2019-2025 | |
| Edwards Lifesciences Corporation | $556.84 | 2020-2025 | Sapien 3 Ultra Resilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $492.78 | 2019-2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $413.92 | 2019-2025 | Uptravi, Opsumit |
| Teleflex LLC | $397.25 | 2023-2025 | Trapliner, Orsiro Mission |
| Pfizer INC. | $390.06 | 2019-2025 | |
| Cagent Vascular INC | $385.65 | 2024-2025 | Serrantor |
| Stryker Corporation | $303.33 | 2025 | Limflow System, Flowtriever |
| Spectrawave, INC | $262.99 | 2024-2025 | Starlight Imaging Catheter, Hypervue Imaging System |
| E.R. Squibb & Sons, L.L.C. | $187.79 | 2019-2025 | Camzyos, Eliquis |
| Endotronix, INC. | $179.70 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Regeneron Healthcare Solutions, INC. | $174.14 | 2019 | |
| Atricure, INC. | $155.63 | 2022 | |
| Heartflow, INC. | $149.77 | 2024 | |
| Allergan, INC. | $145.54 | 2021 | |
| Angiodynamics, INC. | $133.94 | 2019-2024 | Auryon Laser System 100-120 Vac |
| Regeneron Pharmaceuticals, INC. | $129.72 | 2019 | |
| Scpharmaceuticals INC. | $127.59 | 2025 | |
| Penumbra, INC. | $123.55 | 2024 | Indigo System |
| Cardinal Health 200 LLC | $121.99 | 2019 | |
| Amarin Pharma, INC. | $103.34 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $81.22 | 2019 | |
| Argon Medical Devices, INC. | $65.45 | 2025 | Clot Management |
| Cvrx, INC. | $55.36 | 2022 | |
| Vifor Pharma, INC. | $47.97 | 2021 | |
| Astellas Pharma US INC | $29.43 | 2021 | |
| Sanofi-Aventis U.S. LLC | $25.00 | 2022 | |
| Novo Nordisk INC | $23.51 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $22.16 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $21.63 | 2024 | |
| Sumitomo Pharma America, INC. | $15.01 | 2024 | Gemtesa |
| Chiesi USA, INC. | $14.80 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$100,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manish Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.